Pages that link to "Item:Q1423286"
From MaRDI portal
The following pages link to Maximum penalized likelihood estimation in a Gamma-frailty model (Q1423286):
Displayed 20 items.
- Statistical models for recurrent events and death: application to cancer events (Q622948) (← links)
- On a convergent stochastic estimation algorithm for frailty models (Q746290) (← links)
- Inference in mixed proportional hazard models with \(K\) random effects (Q841002) (← links)
- Regression analysis of bivariate current status data under the gamma-frailty proportional hazards model using the EM algorithm (Q1623788) (← links)
- Cause-specific hazard regression for competing risks data under interval censoring and left truncation (Q1658741) (← links)
- Posterior consistency in frailty models and simulation studies to test the presence of random effects (Q1726173) (← links)
- A Gamma-frailty proportional hazards model for bivariate interval-censored data (Q1796967) (← links)
- Modeling interval-censored, clustered cow udder quarter infection times through the shared gamma frailty model (Q2259962) (← links)
- Small sample bias in the gamma frailty model for univariate survival (Q2575273) (← links)
- Correlated versus uncorrelated frailty Cox models: A comparison of different estimation procedures (Q2829472) (← links)
- Outcome Prediction for Heart Failure Telemonitoring Via Generalized Linear Models with Functional Covariates (Q2852619) (← links)
- A new approach for joint modelling of longitudinal measurements and survival times with a cure fraction (Q2856535) (← links)
- Smoothing Spline ANOVA Frailty Model for Recurrent Event Data (Q2893391) (← links)
- Bias Reduction of Likelihood Estimators in Semiparametric Frailty Models (Q3077798) (← links)
- A note on the prediction of frailties with misspecified shared frailty models (Q5033948) (← links)
- Confidence intervals for the difference between two median survival times for clustered survival data (Q5138163) (← links)
- Influence of trial duration on the bias of the estimated treatment effect in clinical trials when individual heterogeneity is ignored (Q5257926) (← links)
- Tumor dormancy and frailty models: A novel approach (Q5347429) (← links)
- A joint frailty‐copula model for meta‐analytic validation of failure time surrogate endpoints in clinical trials (Q6071311) (← links)
- Functional modeling of recurrent events on time‐to‐event processes (Q6091676) (← links)